As of 2025-10-31, the Relative Valuation of Biovaxys Technology Corp (BIOV.CN) is (0.01) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.24 CAD, the upside of Biovaxys Technology Corp based on Relative Valuation is -103.7%.
The range of the Relative Valuation is (0.01) - (0.01) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.0x - 0.1x | 0.0x |
| Forward P/E multiples | 0.0x - 0.1x | 0.0x |
| Fair Price | (0.01) - (0.01) | (0.01) |
| Upside | -103.0% - -104.4% | -103.7% |
| Date | P/E |
| 2025-10-29 | -1.35 |
| 2025-10-28 | -1.41 |
| 2025-10-27 | -1.09 |
| 2025-10-24 | -1.67 |
| 2025-10-23 | -1.49 |
| 2025-10-22 | -1.32 |
| 2025-10-21 | -1.15 |
| 2025-10-20 | -0.98 |
| 2025-10-17 | -1.44 |
| 2025-10-16 | -1.41 |
| 2025-10-15 | -1.49 |
| 2025-10-10 | -1.55 |
| 2025-10-09 | -1.78 |
| 2025-10-08 | -1.49 |
| 2025-10-07 | -1.64 |
| 2025-10-06 | -1.70 |
| 2025-10-02 | -1.75 |
| 2025-10-01 | -1.58 |
| 2025-09-30 | -1.58 |
| 2025-09-29 | -1.44 |
| 2025-09-26 | -1.67 |
| 2025-09-25 | -1.67 |
| 2025-09-24 | -1.49 |
| 2025-09-23 | -1.67 |
| 2025-09-22 | -1.47 |
| 2025-09-19 | -1.41 |
| 2025-09-18 | -1.67 |
| 2025-09-17 | -1.38 |
| 2025-09-16 | -1.41 |
| 2025-09-15 | -1.29 |
| 2025-09-12 | -1.44 |
| 2025-09-11 | -1.67 |
| 2025-09-10 | -1.72 |
| 2025-09-09 | -1.72 |
| 2025-09-08 | -1.44 |
| 2025-09-05 | -14.37 |
| 2025-09-04 | -1.72 |
| 2025-09-03 | -1.44 |
| 2025-09-02 | -1.72 |
| 2025-08-29 | -1.72 |
| 2025-08-28 | -1.72 |
| 2025-08-27 | -1.72 |
| 2025-08-26 | -2.01 |
| 2025-08-22 | -2.01 |
| 2025-08-21 | -1.44 |
| 2025-08-20 | -1.44 |
| 2025-08-18 | -1.44 |
| 2025-08-15 | -1.44 |
| 2025-08-14 | -1.44 |
| 2025-08-13 | -1.44 |